| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/07/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 600k | $3.60 | $2.2M | See Footnote | 09/07/2022 |
| 08/16/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Pre-funded Warrants (right to buy) | 1.5M | $0.00 | $150 | See Footnote | 08/12/2022 |
| 08/16/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 1.5M | $2.42 | $3.6M | See Footnote | 08/12/2022 |
| 08/15/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 1.2k | $2.99 | $3.6k | See Footnote | 08/12/2022 |
| 08/12/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 1.1M | $2.98 | $3.3M | See Footnote | 08/12/2022 |
| 06/16/2022 | Terns Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 32k | $1.82 | $58.2k | | 06/16/2022 |
| 02/24/2021 | Terns Pharmaceuticals, Inc. | | Grant | Stock Option (Right to Buy) | 25k | $22.06 | $551.5k | | 02/24/2021 |
| 11/21/2019 | AVEDRO INC | AVDR | Disposition | Restricted Stock Units | 3k | $0.00 | $0 | | 11/21/2019 |
| 11/21/2019 | AVEDRO INC | AVDR | Disposition | Stock Option (right to buy) | 8.3k | $12.73 | $105.8k | | 11/21/2019 |
| 06/14/2019 | AVEDRO INC | AVDR | Grant | Restricted Stock Units | 3k | $0.00 | $0 | | 06/14/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Purchase | Common Stock | 60k | $18.00 | $1.1M | By LAV Prime Limited | 04/22/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Conversion | Common Stock | 546.8k | $0.00 | $0 | By LAV Prime Limited | 04/22/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Conversion | Common Stock | 1.1M | $0.00 | $0 | By LAV Prime Limited | 04/22/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Grant | Stock Option (right to buy) | 15k | $27.06 | $405.9k | | 04/22/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Conversion | Series C Preferred Stock | 4.3M | $0.00 | $0 | By LAV Prime Limited | 04/22/2019 |
| 04/22/2019 | Turning Point Therapeutics, Inc. | TPTX | Conversion | Series D Preferred Stock | 2.1M | $0.00 | $0 | By LAV Prime Limited | 04/22/2019 |
| 02/19/2019 | AVEDRO INC | AVDR | Grant | Stock Option (right to buy) | 8.3k | $12.73 | $105.8k | | 02/19/2019 |